Demonstrating comparability in AAV analytical development with mass photometry

Empty capsids in AAV-based gene therapy samples can complicate vector purification and reduce product safety. Watch this webinar to learn:  

• How mass photometry provides fast, serotype-independent AAV analytics  

• Why its strengths make it ideal for efficient, in-process sample characterization 

• Insights from an expert working at Sangamo Therapeutics on how to establish an analytical workflow in AAV development and production 

• How mass photometry enhances GMP-regulated environments and process optimization